Please login to the form below

Not currently logged in
Email:
Password:

Teva's vice chair steps down

Amir Elstein to take over from Moshe Many
Teva Amir Elstein

Teva faces yet more senior changes as Prof Moshe Many announced his intention to step down as vice chairman at the beginning of next year.

According to Teva, Prof Many is leaving his position for “personal reasons” and will be replaced by board director Amir Elstein. This change will take place on January 1, 2014.

It is second major change at the top for Teva in recent months after the company announced its president and CEO Jeremy Levin was stepping down after just 18 months in the position.

Commenting on Prof Many's decision to step down, Teva's chairman Dr Phillip Frost said: "I would like to thank Prof Many for his outstanding service as vice chairman and wish Amir success in continuing Moshe's good work."

16th December 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics